Genmab — November 2017
-
Ny hæder til Florian. http://medwatch.dk/secure/Medicinal___Biotek/article9993109.ece
-
who could make a comm
ent on the smoldering abstract? ( centaurus, #510, https://ash.confex.com/ash/2017/webprogram/Paper106028.html ) -
Jeg er enig med TheNote i at en behandling med CAR-T er meget billigere end 5 års dara/rev/dex. Så prismæssigt har CAR-T er Formel!
-
Bivirkninger p.t. givetvis til fordel for dara/rev/dex eller dara/pom/dex
-
fordel
-
agee EL
-
Speaking of CAR-T. Juno was up 7.5% yesterday. Is now up 140% YTD. Someone is beliebig in this CAR-T stuff. They certainly must all be some blind retail shareholders being fuelled by the big Boys

-
believing - fooled
-
Har været lidt inde på det tidligere, når man ser på Q/A. Der har været en tildens til at man ikke svare konkret på de mere negativt rettede spørgsmål. Det er meget nemt til Q&A at vige uden om kritiske spørgsmål. Faren er at der begynder at være skeletter i skabet............
-
The Note har helt klart fat i kernen..... det er værd at debattere..... jeg har længe forsøgt at få noget realisme ind i Genmab casen...... det kunne nu se ud som om det er på vej.....mange har ligget på knæ for Jan W.... optimisme er en god ting, men realisme er nu bedre...
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind